Physician
Kasper, Amy
Kasper, Amy was paid $159K by Medicaid between Jan 2018 and Mar 2023, across 14 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 38% of everything it billed.
33Billing provider infoKASPER, AMY
WILBRAHAM, MA 01095
WILBRAHAM, MA 01095
33aNPI1992791800assigned 09/26/2005
33bProvider typePediatric Adolescent Medicine Physician
28Total paid$159K
24GClaims5,387
24DCodes billed14
24AFirst – last monthJan 2018 – Mar 2023
Compared with peers
Next to other Pediatric Adolescent Medicine Physician providers in Massachusetts
Rank by total paid#23 of 54
Median peer was paid$119K
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 719 | $31K | |
| 2019 | 692 | $22K | |
| 2020 | 520 | $14K | |
| 2021 | 952 | $26K | |
| 2022 | 1,991 | $53K | |
| 2023 | 513 | $13K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 38% | 1,064 | 1,045 | $60K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 317 | 306 | $30K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 12% | 491 | 489 | $19K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 7.3% | 227 | 225 | $12K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 6.3% | 1,088 | 1,085 | $10K |
| 96127 | 5.5% | 670 | 620 | $9K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3.3% | 225 | 221 | $5K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3.2% | 371 | 362 | $5K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.3% | 43 | 43 | $4K |
| 94760 | <1% | 746 | 728 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 60 | 60 | $1K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 31 | 31 | $959.45 |
2 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.